IL119418A - Use of nk-1 receptor antagonists in combination with other agents in the preparation of anti-emetic medicaments, and pharmaceutical compositions comprising same - Google Patents

Use of nk-1 receptor antagonists in combination with other agents in the preparation of anti-emetic medicaments, and pharmaceutical compositions comprising same

Info

Publication number
IL119418A
IL119418A IL11941896A IL11941896A IL119418A IL 119418 A IL119418 A IL 119418A IL 11941896 A IL11941896 A IL 11941896A IL 11941896 A IL11941896 A IL 11941896A IL 119418 A IL119418 A IL 119418A
Authority
IL
Israel
Prior art keywords
phenylpiperidine
amino
methoxybenzylamino
methoxy
azabicyclo
Prior art date
Application number
IL11941896A
Other languages
English (en)
Other versions
IL119418A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL119418A0 publication Critical patent/IL119418A0/xx
Publication of IL119418A publication Critical patent/IL119418A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11941896A 1995-10-20 1996-10-14 Use of nk-1 receptor antagonists in combination with other agents in the preparation of anti-emetic medicaments, and pharmaceutical compositions comprising same IL119418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US572895P 1995-10-20 1995-10-20

Publications (2)

Publication Number Publication Date
IL119418A0 IL119418A0 (en) 1997-01-10
IL119418A true IL119418A (en) 2001-07-24

Family

ID=21717419

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11941896A IL119418A (en) 1995-10-20 1996-10-14 Use of nk-1 receptor antagonists in combination with other agents in the preparation of anti-emetic medicaments, and pharmaceutical compositions comprising same

Country Status (9)

Country Link
EP (1) EP0769300A3 (ja)
JP (1) JPH09110721A (ja)
CN (1) CN1151893A (ja)
AU (1) AU700841B2 (ja)
CA (1) CA2188227C (ja)
IL (1) IL119418A (ja)
NZ (1) NZ299606A (ja)
TW (1) TW458774B (ja)
ZA (1) ZA968790B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2149767T5 (es) 1991-09-20 2005-06-16 Glaxo Group Limited Nuevo uso medico para antagonistas de taquiquininas.

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0360390A1 (en) 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
MX18467A (es) 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
FI97540C (fi) 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
US5232929A (en) 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
WO1992006079A1 (en) 1990-09-28 1992-04-16 Pfizer Inc. Fused ring analogs of nitrogen containing nonaromatic heterocycles
AU652407B2 (en) 1991-01-10 1994-08-25 Pfizer Inc. N-alkyl quinuclidinium salts as substance P antagonists
ATE154354T1 (de) 1991-02-11 1997-06-15 Merck Sharp & Dohme Azabicyclische verbindungen, diese enthaltende pharmazeutische zubereitungen und ihre therapeutische verwendung
DK0573522T3 (da) 1991-03-01 1995-03-06 Pfizer 1-Azabicyclo(3,2,2)nonan-3-aminderivater
WO1992020661A1 (en) 1991-05-22 1992-11-26 Merck & Co., Inc. N, n-diacylpiperazines
DE9290057U1 (de) 1991-05-22 1994-01-05 Pfizer Inc., New York, N.Y. Substituierte 3-Aminochinuclidine
DK0587723T3 (da) 1991-05-31 1996-04-01 Pfizer Quinuclidinderivater
ATE142199T1 (de) 1991-06-20 1996-09-15 Pfizer Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen
TW202432B (ja) 1991-06-21 1993-03-21 Pfizer
US5288730A (en) 1991-06-24 1994-02-22 Merck Sharp & Dohme Limited Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
IE72090B1 (en) 1991-07-05 1997-03-12 Merck Sharp & Dohme Aromatic compounds pharmaceutical compositions containing them and their use in therapy
EP0593559A1 (en) 1991-07-05 1994-04-27 MERCK SHARP & DOHME LTD. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
JPH06509090A (ja) 1991-07-10 1994-10-13 メルク　シヤープ　エンド　ドーム　リミテツド 芳香族化合物、それらを含む組成物、及び治療におけるそれらの使用
WO1993001159A1 (en) 1991-07-10 1993-01-21 Merck Sharp & Dohme Limited Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993004040A1 (en) 1991-08-20 1993-03-04 Merck Sharp & Dohme Limited Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them
ES2149767T5 (es) 1991-09-20 2005-06-16 Glaxo Group Limited Nuevo uso medico para antagonistas de taquiquininas.
CA2118704C (en) 1991-09-26 1997-01-21 John A. Lowe, Iii Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists
HUT70741A (en) 1991-11-12 1995-10-30 Pfizer Acyclic ethylenediamine derivatives as substance p receptor antagonists
DE4143345B4 (de) 1991-12-04 2007-03-22 Rieter Ingolstadt Spinnereimaschinenbau Ag Drehteller einer Spinnereivorbereitungsmaschine
GB9201179D0 (en) 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
JP2656702B2 (ja) 1992-03-23 1997-09-24 ファイザー製薬株式会社 ペプチド性キヌクリジン
PT655996E (pt) 1992-08-19 2002-04-29 Pfizer Benzilaminas substituidas contendo heterociclicos nao aromaticos contendo azoto
JP2656699B2 (ja) 1992-10-21 1997-09-24 ファイザー製薬株式会社 置換ベンジルアミノキヌクリジン
CA2150123C (en) 1992-12-10 2004-12-07 Harry R. Howard Aminomethylene substituted non-aromatic heterocycles
DK0687268T3 (da) 1993-03-04 1998-10-12 Pfizer Spiroazacykliske derivater som substans P-antagonister
GB9305718D0 (en) 1993-03-19 1993-05-05 Glaxo Group Ltd Medicaments
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
GB9315808D0 (en) 1993-07-30 1993-09-15 Merck Sharp & Dohme Therapeutic agents
GB9317987D0 (en) * 1993-08-26 1993-10-13 Glaxo Group Ltd Chemical compounds
IS4208A (is) 1993-09-22 1995-03-23 Glaxo Group Limited 3-(tetrazólýl-benzyl)amínó-piperadidín afleiður
ES2120170T3 (es) 1994-01-13 1998-10-16 Merck Sharp & Dohme Antagonistas azaciclicos gem-disustituidos de taquiquininas.
AU1462795A (en) 1994-01-28 1995-08-15 Merck Sharp & Dohme Limited Aralkylamino substituted azacyclic therapeutic agents
PE45195A1 (es) 1994-03-03 1996-01-17 Boehringer Ingelheim Kg Derivado de aminoacido, procedimiento para su preparacion y composicion farmaceutica que lo contiene
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
NZ299606A (en) 2000-07-28
EP0769300A3 (en) 1999-11-24
MX9605030A (es) 1997-09-30
CA2188227A1 (en) 1997-04-21
CA2188227C (en) 2000-08-08
AU700841B2 (en) 1999-01-14
CN1151893A (zh) 1997-06-18
JPH09110721A (ja) 1997-04-28
TW458774B (en) 2001-10-11
IL119418A0 (en) 1997-01-10
ZA968790B (en) 1998-04-20
AU7027996A (en) 1997-05-15
EP0769300A2 (en) 1997-04-23

Similar Documents

Publication Publication Date Title
CA2164689C (en) Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
EP0533280B2 (en) Novel medical use for tachykinin antagonists
CZ187097A3 (cs) Farmaceutický prostředek
EP0627221A2 (en) Substance P antagonists for the treatment of emesis
US20150374712A1 (en) Combinations of Dopamine D2 Receptor Blockade With Norepinephrine Reuptake Inhibition and with Norepinephrine Alpha 2 Receptor Blockade
WO2004000355A1 (en) Combination treatment for depression and anxiety by nk1 and nk3 antagonists
US5519033A (en) Azabicyclo derivatives for treatment of urinary incontinence
CA2728514C (en) Paediatric compositions for treating multiple sclerosis
US6376507B1 (en) NK-1 receptor antagonists for the treatment of neuronal injury and stroke
US6194436B1 (en) NK-1 receptor antagonists for the treatment of cancer
EP1192952A2 (en) Combination, for treating depression and anxiety, containing an NK-3 receptor antagonist and a CNS penetrant NK-1 receptor antagonist
CA2188227C (en) Combination antiemetic therapy using nk-1 receptor antagonists
EP0854720B1 (en) Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
US20040001895A1 (en) Combination treatment for depression and anxiety
WO1996014845A1 (en) Nk-1 receptor antagonists for the treatment of eye disorders
AU2021200647A1 (en) Paediatric compositions for treating multiple sclerosis
EP0659409A2 (en) Substance 1 antagonists for the inhibition of angiogenesis
MXPA96005030A (en) Antiemetic combination therapy using receptor antagonists n
EP1095655A2 (en) NK-1 receptor antagonists and eletriptan for the treatment of migraine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force